Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
2(25%)

Phase Distribution

Ph phase_2
2
25%
Ph not_applicable
2
25%
Ph phase_1
1
13%
Ph phase_3
1
13%
Ph phase_4
2
25%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(3)
Terminated(2)
Other(3)

Detailed Status

unknown3
Completed3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 22 (25.0%)
Phase 31 (12.5%)
Phase 42 (25.0%)
N/A2 (25.0%)

Trials by Status

terminated225%
unknown338%
completed338%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

NCT04497168
completednot_applicable

Serotonin, Anxiety and Visceral Sensation

NCT06212284
unknownphase_3

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

NCT06025474
unknownphase_1

REward Processing And Citalopram Study

NCT06017037
terminatedphase_4

Effect of Citalopram on Chest Pain in Patients With Functional Chest Pain

NCT05735756
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04497168Phase 2

Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

Completed
NCT06212284Not Applicable

Serotonin, Anxiety and Visceral Sensation

Completed
NCT06025474Phase 3

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

Unknown
NCT06017037Phase 1

REward Processing And Citalopram Study

Unknown
NCT05735756Phase 4

Effect of Citalopram on Chest Pain in Patients With Functional Chest Pain

Terminated
NCT05346445Not Applicable

Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

Completed
NCT03499171Phase 4

Citalopram for Reflux Hypersensitivity and Functional Heartburn

Unknown
NCT00218036Phase 2

Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8

Terminated

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8